The pharma industry is moving beyond the borders of US and Western Europe. As drug development costs reach astronomical levels, the burden to become lean falls on the manufacturers. To reduce costs, companies are moving their manufacturing facilities to off-shore locations, creating a need for an end-to-end SCM solution that allows them to gain visibility and manage their global drug supply chain.
Scope
- Identifies the key forces driving the adoption of SCM solutions in the pharma industry
- Analyzes the crucial issues that will impede the uptake of supply chain management tools
- Discusses the key functionalities pharma requires from a robust SCM solution
- Offers insight into how IT vendors can improve their products to target pharma
Highlights of this title
In order to handle the new changes that are quickly approaching the pharma and biotech manufacturing industry, adoption of a robust SCM solution that allows companies to manage the complex supply chain and trace the drug and its components from sourcing through patient will be required.
The adoption of SCM solutions will help pharma companies aggregate data from across the supply chain and provide managers with detailed information regarding the status and location of all raw materials and finished products as they move from sourcing through production through distribution to patient.
The emerging markets have provided companies with low cost materials and manufacturing as well as new sales channels. However, products from these regions have proven to be of questionable quality. SCM eases the task of managing the global drug supply chain. Since SCM is relatively new to pharma, there are great opportunities for SCM vendors.
Key reasons to purchase this title
- Validate your market messaging and positioning in the pharmaceutical industry
- Identify strategies that will increase adoption of SCM technologies
- Understand the technology trends that are shaping the future of pharma manufacturing
